BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32793239)

  • 1. Editorial: Autoimmune Blistering Diseases.
    Kowalewski C; Hashimoto T; Joly P
    Front Immunol; 2020; 11():1614. PubMed ID: 32793239
    [No Abstract]   [Full Text] [Related]  

  • 2. Milestones in Personalized Medicine in Pemphigus and Pemphigoid.
    Bieber K; Kridin K; Emtenani S; Boch K; Schmidt E; Ludwig RJ
    Front Immunol; 2020; 11():591971. PubMed ID: 33505392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune blistering skin diseases.
    Cotell S; Robinson ND; Chan LS
    Am J Emerg Med; 2000 May; 18(3):288-99. PubMed ID: 10830686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapy of autoimmune blistering diseases.
    Alaibac M
    Expert Opin Biol Ther; 2019 Feb; 19(2):149-156. PubMed ID: 30558452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune bullous diseases: diagnosis and management.
    McCuin JB; Hanlon T; Mutasim DF
    Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.
    Schmidt E; Spindler V; Eming R; Amagai M; Antonicelli F; Baines JF; Belheouane M; Bernard P; Borradori L; Caproni M; Di Zenzo G; Grando S; Harman K; Jonkman MF; Koga H; Ludwig RJ; Kowalczyk AP; Müller EJ; Nishie W; Pas H; Payne AS; Sadik CD; Seppänen A; Setterfield J; Shimizu H; Sinha AA; Sprecher E; Sticherling M; Ujiie H; Zillikens D; Hertl M; Waschke J
    J Invest Dermatol; 2017 Jun; 137(6):1199-1203. PubMed ID: 28390814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus and bullous pemphigoid.
    Nousari HC; Anhalt GJ
    Lancet; 1999 Aug; 354(9179):667-72. PubMed ID: 10466686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three blistering diseases. Why proper management is critical.
    Wooldridge WE
    Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune blistering diseases].
    Amagai M
    Nihon Rinsho; 2005 May; 63 Suppl 5():540-6. PubMed ID: 15954407
    [No Abstract]   [Full Text] [Related]  

  • 11. Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.
    Kartan S; Shi VY; Clark AK; Chan LS
    Am J Clin Dermatol; 2017 Feb; 18(1):105-126. PubMed ID: 27878477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune blistering skin diseases in childhood.
    Marinović B; Jukić IL
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):33-7. PubMed ID: 12137729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating consensus research goals and treatment strategies for pemphigus and pemphigoid: The 2010 JC Bystryn Pemphigus and Pemphigoid Meeting.
    Schultz HY; Diaz LA; Sirois DA; Werth VP; Grando SA
    J Invest Dermatol; 2011 Jul; 131(7):1395-9. PubMed ID: 21673705
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune bullous diseases.
    Rye B; Webb JM
    Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and classification of autoimmune blistering diseases.
    Baum S; Sakka N; Artsi O; Trau H; Barzilai A
    Autoimmun Rev; 2014; 13(4-5):482-9. PubMed ID: 24434358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
    Jolles S
    Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic approach to autoimmune blistering diseases using immunoblotting with chemiluminescence.
    Kitamura T; Tamada Y; Takama H; Yokochi K; Nitta Y; Ikeya T
    J Dermatol; 1994 Sep; 21(9):652-4. PubMed ID: 7962968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nail changes in autoimmune blistering disorders: A case-control study.
    Gopal V; Shenoy MM; Bejai V; Nargis T
    Indian J Dermatol Venereol Leprol; 2018; 84(3):373. PubMed ID: 29327699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.